Journal Information
Vol. 60. Issue S2.
Lung cancer: New perspectives
Pages S77-S85 (October 2024)
Share
Share
Download PDF
More article options
Vol. 60. Issue S2.
Lung cancer: New perspectives
Pages S77-S85 (October 2024)
Review Article
Tertiary Lymphoid Structure in Tumor Microenvironment and Immunotherapy of Lung Cancer
Visits
788
Mei Xiea,1, Xuwen Lina,1, Xinyu Baob,1, Yiran Lianga, Hui Denga, Jialin Songb, Xidong Maa, Xin Zhangb, Jie Yaoa, Lei Pana,
Corresponding author
leipan2010@163.com

Corresponding author.
, Xinying Xuea,
Corresponding author
xuexinying2988@bjsjth.cn

Corresponding author.
a Department of Respiratory and Critical Care, Emergency and Critical Care Medical Center, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, People's Republic of China
b Department of Respiratory and Critical Care, Shandong Second Medical University, School of Clinical Medicine, Shandong Second Medical University, Weifang, People's Republic of China
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (3)
Show moreShow less
Tables (1)
Table 1. Predictive Functions of TLSs in Immunotherapy-treated Lung Cancer Patients.
Special issue
This article is part of special issue:
Vol. 60. Issue S2

Lung cancer: New perspectives

More info
Abstract

Immune checkpoint inhibitors have opened an era of lung cancer therapy. However, a notable disparity exists in the efficacy of immunotherapy among individual patients. The tertiary lymphoid structure (TLS) is an ectopic lymphocyte aggregation that appears under pathological conditions and is the primary site of action for anti-tumor immunity. It is commonly reported that the presence of TLS within the tumor microenvironment (TME) relates to a favorable clinical prognosis and an excellent response to immunotherapy in lung cancer patients. A thorough understanding of TLS and its dynamic changes in TME has become an attractive focus for optimizing immunotherapy strategies for lung cancer. In this review, we comprehensively generalize the composition, formation, mechanism, detection methods of TLS, and summarize the role of TLS in lung cancer immunotherapy. Finally, induction of TLS is also discussed, which may provide more effective therapeutic strategies for lung cancer therapy.

Keywords:
Tertiary lymphoid structures
Lung cancer
Immunotherapy
Prognosis
Abbreviations:
ADCC
ADCP
APCs
BCRs
COPD
CDC
CT
CXCL13
CTLs
DCs
DFS
DCR
E-TLS
FDC
(Tfh) cells
FRC
GC
(Th) cells
HE
HEV
ICBs
IHC
ICAM1
IL-21
IL-17
IL-7
LUAD
LUSC
(LTi) cells
LTα1β2
LTβR
MRI
MPR
mIF
NSCLC
OS
pCR
PNAd
PCs
PET
PFL-TLS
PFS
Tregs
RNA-seq
SFL-TLS
SLOs
SPECT
SHM
STING
TCR
TLSs
Ti-BALT
TME
VCAM1
VEGFC

Article

These are the options to access the full texts of the publication Archivos de Bronconeumología
Member
If you are a member of SEPAR:
  • Go to >>>SEPAR<<< website and sign in.
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Archivos de Bronconeumología

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Email
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?